Natixis Advisors, L.P. Bruker Corp Transaction History
Natixis Advisors, L.P.
- $63 Billion
- Q2 2025
A detailed history of Natixis Advisors, L.P. transactions in Bruker Corp stock. As of the latest transaction made, Natixis Advisors, L.P. holds 478,757 shares of BRKR stock, worth $16.7 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
478,757
Previous 310,222
54.33%
Holding current value
$16.7 Million
Previous $12.9 Million
52.34%
% of portfolio
0.03%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding BRKR
# of Institutions
407Shares Held
117MCall Options Held
237KPut Options Held
747K-
T. Rowe Price Investment Management, Inc. Baltimore, MD11.4MShares$398 Million0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.4MShares$363 Million0.01% of portfolio
-
Black Rock Inc. New York, NY9.83MShares$342 Million0.01% of portfolio
-
Pallas Capital Advisors LLC Braintree, MA9.5MShares$331 Million16.14% of portfolio
-
Orbis Allan Gray LTD Hamilton, D04.68MShares$163 Million1.26% of portfolio
About BRUKER CORP
- Ticker BRKR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 148,138,000
- Market Cap $5.16B
- Description
- Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, ...